Login to Your Account



Acadia Raises $89.1M Publicly To Fund Upcoming CNS Trials

By Jim Shrine


Friday, April 6, 2007
Acadia Pharmaceuticals Inc. capitalized on the recent jump in its shares, pricing an $89.1 million public offering. The San Diego-based company sold 5.75 million shares at $15.50 per share, an offering expected to net $83.5 million. Underwriters have a 30-day overallotment option on 862,500 additional shares, which would add about $13.4 million to the gross proceeds if exercised. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription